Interim Report January - June 1999

INTERIM REPORT JANUARY - JUNE 1999 * Sales increased by 4%. * Strong recovery in Japan led to a sales increase of 34% in Asia-Pacific. * Expansion of the sales and marketing organization, primarily in Japan, was the main reason for the decrease of earnings per share by 5%. * Successful entry into drug discovery applications with BIACORE3 000 - increased efforts initiated. * For the full-year 1999, a sales increase in line with the earlier forecast is expected, i.e. in the range of 10%. ------------------------------------------------------------ Please visit http://www.bit.se for further information The following files are available for download: http://www.bit.se/bitonline/1999/07/16/19990716BIT00250/bit0001.doc http://www.bit.se/bitonline/1999/07/16/19990716BIT00250/bit0002.pdf